scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0165-5728(99)00271-4 |
P698 | PubMed publication ID | 10713348 |
P2093 | author name string | S C Miller | |
L Z Sun | |||
N L Currier | |||
P2860 | cites work | Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow | Q34247644 |
Interleukin 2-induced proliferation of murine natural killer cells in vivo | Q36350213 | ||
Effect of melatonin on activated macrophage TNF, IL-6, and reactive oxygen intermediates. | Q41030130 | ||
Biological function and distribution of human interleukin-12 receptor beta chain | Q41234457 | ||
Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications | Q41377025 | ||
Enkephalins in hematopoiesis | Q41401203 | ||
Melatonin and the immune-hematopoietic system therapeutic and adverse pharmacological correlates | Q41574097 | ||
The photoperiod transducer melatonin and the immune-hematopoietic system | Q43070741 | ||
Pineal-opioid system interactions in the control of immunoinflammatory responses | Q44335582 | ||
kappa-Opioid receptors in marrow stroma mediate the hematopoietic effects of melatonin-induced opioid cytokines | Q44349058 | ||
Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection | Q44902476 | ||
Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat. | Q47848905 | ||
Exogenous melatonin enhances cell-mediated, but not humoral, immune function in adult male deer mice (Peromyscus maniculatus). | Q48006782 | ||
Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone | Q48284579 | ||
Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation | Q48294259 | ||
Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans | Q48365838 | ||
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma | Q48869346 | ||
Daily melatonin treatments regulate the circadian melatonin rhythm in the adult Djungarian hamster | Q49095349 | ||
Fluctuation of blood melatonin concentrations with age: result of changes in pineal melatonin secretion, body growth, and aging | Q49158622 | ||
Pharmacokinetics of melatonin in human sexual maturation. | Q51033617 | ||
Effect of melatonin and corticosteroid on in vitro cellular immune function in humans. | Q52525855 | ||
Melatonin Administration Attenuates Depressed Immune Functions after Trauma-Hemorrhage | Q60156931 | ||
Small lymphocyte production and lymphoid cell proliferation in mouse bone marrow | Q67014331 | ||
Population Dynamics of Natural Killer Cells in the Spleen and Bone Marrow of Normal and Leukemic Mice during in vivo Exposure to Interleukin-2 | Q67872220 | ||
The pineal control of aging. The effects of melatonin and pineal grafting on the survival of older mice | Q67924582 | ||
Granulocyte-monocyte progenitor cells from human peripheral blood: modulation of growth in vitro by T lymphocytes and monocytes | Q68090707 | ||
Enhancement of porcine natural killer cell activity by recombinant human and murine IL-12 | Q71530921 | ||
High-affinity binding of melatonin by human circulating T lymphocytes (CD4+) | Q71737061 | ||
Effectiveness of immunotherapy in aged leukemic mice | Q71738518 | ||
A glycolipid on the surface of mouse natural killer cells | Q72075905 | ||
Decline in natural killer cell-mediated immunosurveillance in aging mice--a consequence of reduced cell production and tumor binding capacity | Q72414660 | ||
Immune responsiveness of splenocytes after chronic daily melatonin administration in male Syrian hamsters | Q73626712 | ||
Long-term melatonin supplementation does not recover the impairment of natural killer cell activity and lymphocyte proliferation in aging mice | Q73666802 | ||
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical st | Q73901028 | ||
Modulation of cytokine production by dehydroepiandrosterone (DHEA) plus melatonin (MLT) supplementation of old mice | Q74509476 | ||
Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice | Q77150418 | ||
Melatonin: immune modulation of spleen cells in young, middle-aged and senescent mice | Q77179770 | ||
Melatonin involvement in immunity and cancer | Q93910071 | ||
P433 | issue | 2 | |
P304 | page(s) | 101-108 | |
P577 | publication date | 2000-05-01 | |
P1433 | published in | Journal of Neuroimmunology | Q15716691 |
P1476 | title | Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity | |
P478 | volume | 104 |
Q22306049 | A Review of the Multiple Actions of Melatonin on the Immune System |
Q36983795 | Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells |
Q38003366 | Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"? |
Q38453610 | Clinically feasible approaches to potentiating cancer cell-based immunotherapies. |
Q42487556 | Effect of melatonin on phagocytic activity and intracellular free calcium concentration in testicular macrophages from normal and streptozotocin-induced diabetic rats |
Q43242992 | Effect of melatonin on proliferation of neonatal cord blood mononuclear cells |
Q45277536 | Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals. |
Q44044581 | Immune stimulation by exogenous melatonin during experimental endotoxemia |
Q92815195 | Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1 |
Q54660309 | Melatonin and Cancer Hallmarks. |
Q33838766 | Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy |
Q41660894 | Melatonin and Hippo Pathway: Is There Existing Cross-Talk? |
Q35666602 | Melatonin and viral infections |
Q26751220 | Melatonin as a potential anticarcinogen for non-small-cell lung cancer |
Q42484391 | Melatonin increases the survival time of animals with untreated mammary tumours: neuroendocrine stabilization. |
Q25255508 | Melatonin, immune function and aging |
Q37552036 | Melatonin--a pleiotropic molecule involved in pathophysiological processes following organ transplantation. |
Q26801192 | Melatonin: a potential intervention for hepatic steatosis |
Q36820644 | Melatonin: buffering the immune system |
Q37007219 | Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. |
Q38076420 | Oxidative stress and immunosenescence: therapeutic effects of melatonin |
Q37731345 | Parental Exposure to Dim Light at Night Prior to Mating Alters Offspring Adaptive Immunity |
Q37097412 | Pharmacological advantages of melatonin in immunosenescence by improving activity of T lymphocytes |
Q34285562 | Potential role of melatonin in prevention and treatment of oral carcinoma |
Q38973727 | The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis |
Q22306026 | The immunotherapeutic potential of melatonin |
Q39310609 | The melatonin immunomodulatory actions in radiotherapy |
Q36453337 | The role of melatonin in immuno-enhancement: potential application in cancer |
Search more.